RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke

Neurological Research

Volumn 35, Issue 5, 2013, Pages 457-464

  Cox, Christopher ^a   Sharp, Frank R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarker; Blood genomics; Gene expression; Microarrays; RNA; Stroke

Indexed keywords

GAMMA INTERFERON; HEAT SHOCK PROTEIN 70; RNA;

BRAIN ISCHEMIA; DISEASE SEVERITY; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; IMMUNE RESPONSE; MICROARRAY ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MICROARRAY ANALYSIS; RNA; STROKE;

EID: 84878283603     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000212     Document Type: Review

References (95)

1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933-44.
2. Kochanek KD, Xu JQ, Murphy SL, Miniño AM, Kung HC. Deaths: final data for 2009. Natl Vital Stat Rep. 2011;60(3):8-9.
3. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-220.
4. Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, et al. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011;42(9):2645-50.
5. Arnaout OM, Rahme RJ, El Ahmadieh TY, Aoun SG, Batjer HH, Bendok BR. Past, present, and future perspectives on the endovascular treatment of acute ischemic stroke. Tech Vasc Interv Radiol. 2012;15(1):87-92.
6. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. Classification of stroke subtypes. Cerebrovasc Dis. 2009;27:493-501.
7. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371(9624):1612-23.
8. Guercini F, Acciarresi M, Agnelli G, Paciaroni M. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost. 2008;6 (4):549-54.
9. Babarro EG, Rego AR, Gonzalez-Juanatey JR. Cardioembolic stroke: call for a multidisciplinary approach. Cerebrovasc Dis. 2009;27(Suppl.1):82-7.
10. Stead LG, Gilmore RM, Bellolio MF, Jain A, Rabinstein AA, Decker WW, et al. Cardioembolic but not other stroke subtypes predict mortality independent of stroke severity at presentation. Stroke research and treatment. 2011.
11. Chalela JA. Evaluating the carotid plaque: going beyond stenosis. Cerebrovasc Dis. 2009;27(Suppl.1):19-24.
12. Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost. 2009;7(Suppl.1):328-31.
13. Wu TC, Grotta JC. Stroke treatment and prevention: five new things. Neurology. 2010;75:S16-21.
14. Bailey EL, McCulloch J, Sudlow C, Wardlaw JM. Potential animal models of lacunar stroke a systematic review. Stroke. 2009;40(6):451-8.
15. Nah HW, Kang DW, Kwon SU, Kim JS. Diversity of single small subcortical infarctions according to infarct location and parent artery disease: analysis of indicators for small vessel disease and atherosclerosis. Stroke. 2010;41:2822-7.
16. Stevenson SF, Doubal FN, Shuler K, Wardlaw JM. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke. 2010;41:e434-42.
17. Chamorro A, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke. 2006;37:291-3.
18. Becker KJ. Modulation of the postischemic immune response to improve stroke outcome. Stroke. 2010;41:S75-8.
19. del Zoppo GJ. Acute anti-inflammatory approaches to ischemic stroke. Ann N Y Acad Sci. 2010;1207:143-8.
20. Downes CE, Crack PJ. Neural injury following stroke: are Tolllike receptors the link between the immune system and the CNS? Br J Pharmacol. 2010;160:1872-88.
21. Elkind MS. Inflammatory mechanisms of stroke. Stroke. 2010;41:S3-8.
22. Hallenbeck J. How inflammation modulates central nervous system vessel activation and provides targets for intervention-a personal perspective. Ann N Y Acad Sci. 2010;1207:1-7.
23. Marsh BJ, Stevens SL, Hunter B, Stenzel-Poore MP. Inflammation and the emerging role of the toll-like receptor system in acute brain ischemia. Stroke. 2009;40:S34-7.
24. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2005;26(5):654-65.
25. Gong C, Hoff JT, Keep RF. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 2000;871(1):57-65.
26. Furuya K, Takeda H, Azhar S, McCarron RM, Chen Y, Ruetzler CA, et al. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study. Stroke. 2001; 32:2665-74.
27. Akopov S, Sercombe R, Seylaz J. Cerebrovascular reactivity: role of endothelium/platelet/leukocyte interactions. Cerebrovasc Brain Metab Rev. 1996;8:11-94.
28. Caplan LR, Fisher M. The endothelium, platelets, and brain ischemia. Rev Neurol Dis. 2007;4:113-21.
29. Clark WM, Coull BM, Briley DP, Mainolfi E, Rothlein R. Circulating intercellular adhesion molecule-1 levels and neu-trophil adhesion in stroke. J Neuroimmunol. 1993;44: 123-5.
30. Franks ZG, Campbell RA, Weyrich AS, Rondina MT. Plateletleukocyte interactions link inflammatory and thromboembolic events in ischemic stroke. Ann N Y Acad Sci. 2010;1207:11-7.
31. Htun P, Fateh-Moghadam S, Tomandl B, Handschu R, Klinger K, Stellos K, et al. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke. 2006;37:2283-7.
32. Beck J, Stummer W, Lehmberg J, Baethmann A, Uhl E. Leukocyte-endothelium interactions in global cerebral ischemia. Acta Neurochir Suppl. 1997;70:53-5.
33. Pries AR, Kuebler WM. Normal endothelium. Handb Exp Pharmacol. 2006;176:1-40.
34. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke. 1996;27:1734-8.
35. Chavez JC, Hurko O, Barone FC, Feuerstein GZ. Pharmacologic interventions for stroke: looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke. 2009;40:e558-63.
36. Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis. 2009;27:295-302.
37. El Husseini N, Laskowitz DT. Clinical application of blood biomarkers in cerebrovascular disease. Expert Rev Neurother. 2010;10:189-203.
38. Elkind MS. Inflammatory markers and stroke. Curr Cardiol Rep. 2009;11:12-20.
39. Foerch C, Montaner J, Furie KL, Ning MM, Lo EH. Invited article: searching for oracles? Blood biomarkers in acute stroke. Neurology. 2009;73:393-9.
40. Jensen MB, Chacon MR, Sattin JA, Levine RL, Vemuganti R. Potential biomarkers for the diagnosis of stroke. Expert Rev Cardiovasc Ther. 2009;7:389-93.
41. Jickling G, Salam A, Mohammad A, Hussain MS, Scozzafava J, Nasser AM, et al. Circulating endothelial progenitor cells and age-related white matter changes. Stroke. 2009;40:3191-6.
42. Montaner J. Blood biomarkers to guide stroke thrombolysis. Front Biosci (Elite Ed). 2009;1:200-8.
43. Reid JS, Fallon JH. U.S. Patent No. 7,790,669. Washington, DC: U.S. Patent and Trademark Office. "Methods for treating neurological deficits by intrastriatal administration of transforming growth factor alpha (TGF-a)." U.S. Patent 7,790,669, issued September 7, 2010.
44. Saenger AK, Christenson RH. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem. 2010;56:21-33.
45. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke. 2009;40:e380-9.
46. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med. 2009;6:e1000145.
47. Yao H, Nakahara T, Nakagawa N, Hashimoto K, Kuroki T. Regional and temporal changes in proteomic profile after middle cerebral artery occlusion with or without reperfusion in rats. Neurochem Res. 2009;34:1999-2007.
48. Zhang X, Guo T, Wang H, He W, Mei H, Hong M, et al. Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS. Am J Clin Pathol. 2008;130:299-304.
49. King MD, Laird MD, Ramesh SS, Youssef P, Shakir B, Vender JR, et al. Elucidating novel mechanisms of brain injury following subarachnoid hemorrhage: an emerging role for neuroproteomics. Neurosurg Focus. 2010;28:E10.
50. Maurer MH, Haux D, Sakowitz OW, Unterberg AW, Kuschinsky W. Identification of early markers for symptomatic vasospasm in human cerebral microdialysate after subarachnoid hemorrhage: preliminary results of a proteome-wide screening. J Cereb Blood Flow Metab. 2007; 27:1675-83.
51. Maurer MH, Haux D, Unterberg AW, Sakowitz OW. Proteomics of human cerebral microdialysate: from detection of biomarkers to clinical application. Proteomics Clin Appl. 2008;2:437-43.
52. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-11.
53. Tang Y, Lu A, Aronow BJ, Sharp FR. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol. 2001;50:699-707.
54. Tang Y, Lu A, Aronow BJ, Wagner KR, Sharp FR. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci. 2002;15:1937-52.
55. Tang Y, Gilbert DL, Glauser TA, Hershey AD, Sharp FR. Blood gene expression profiling of neurologic diseases: a pilot microarray study. Arch Neurol. 2005;62:210-5.
56. Walker WL, Liao IH, Gilbert DL, Wong B, Pollard KS, McCulloch CE, et al. Empirical Bayes accomodation of batcheffects in microarray data using identical replicate reference samples: application to RNA expression profiling of blood from Duchenne muscular dystrophy patients. BMC Genomics. 2008;9:494.
57. Tang Y, Hershey AD, Powers SW, Gilbert DL, Glauser TA, Sharp FR. Genomic abnormalities in patients with migraine and chronic migraine: blood gene expression evidence of platelet abnomalities. Headache. 2004;44:994-1004.
58. Tang Y, Lu A, Ran R, Aronow BJ, Schorry EK, Hopkin RJ, et al. Human blood genomics: distinct profiles for gender, age and neurofibromatosis type 1. Brain Res Mol Brain Res. 2004;132:155-67.
59. Tang Y, Schapiro MB, Franz DN, Patterson BJ, Hickey FJ, Schorry EK, et al. Blood expression profiles for tuberous sclerosis complex 2, neurofibromatosis type 1, and Down's syndrome. Ann Neurol. 2004;56:808-14.
60. Tang Y, Nee AC, Lu A, Ran R, Sharp FR. Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab. 2003;23:310-9.
61. Zhan X, Kim C, Sharp FR. Very brief focal ischemia simulating transient ischemic attacks (TIAs) can injure brain and induce Hsp70 protein. Brain Res. 2008;1234:183-97.
62. Zhan X, Ander BP, Jickling G, Turner R, Stamova B, Xu H, et al. Brief focal cerebral ischemia that simulates transient ischemic attacks in humans regulates gene expression in rat peripheral blood. J Cereb Blood Flow Metab. 2010;30:110-8.
63. Moore DF, Li H, Jeffries N, Wright V, Cooper Jr RA, Elkahloun A, et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation. 2005;111:212-21.
64. Faas MM, Bouman A, van Nieuwenhoven ALV, van der Schaaf G, Moes H, Heineman MJ, et al. Species differences in the effect of pregnancy on lymphocyte cytokine production between human and rat. J Leukoc Biol. 2005;78(4):946-53.
65. Johnson JL, Moore EE, Hiester AA, Tamura DY, Zallen G, Silliman CC. Disparities in the respiratory burst between human and rat neutrophils. J Leukoc Biol. 1999;65(2):211-6.
66. Davenpeck KL, Sterbinsky SA, Bochner BS. Rat neutrophils express a4 and b1 integrins and bind to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Blood. 1998;91(7):2341-6.
67. Turner R, Jickling GC, Sharp FR. Are underlying assumptions of current animal models of human stroke correct: from STAIRs to high hurdles? Transl Stroke Res. 2011;2(2):138-143.
68. Holmes D, Pettigrew D, Reccius CH, Gwyer JD, van Berkel C, Holloway J, et al. Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometry. Lab Chip. 2009;9:2881-9.
69. Kotz KT, Xiao W, Miller-Graziano C, Qian WJ, Russom A, Warner EA, et al. Clinical microfluidics for neutrophil genomics and proteomics. Nat Med. 2010;16:1042-7.
70. Lee D, Chen PJ, Lee GB. The evolution of real-time PCR machines to real-time PCR chips. Biosens Bioelectron. 2010;25:1820-4.
71. Shim JS, Browne AW, Ahn CH. An on-chip whole blood/ plasma separator with bead-packed microchannel on COC polymer. Biomed Microdevices. 2010;12:949-57.
72. Tang Y, Xu H, Du X, Lit L, Walker W, Lu A, et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab. 2006;26:1089-102.
73. Stamova B, Xu H, Jickling G, Bushnell C, Tian Y, Ander BP, et al. Gene expression profiling of blood for the prediction of ischemic stroke. Stroke. 2010;41:2171-7.
74. Barr TL, Conley Y, Ding J, Dillman A, Warach S, Singleton A, et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology. 2010;75:1009-14.
75. Xu H, Tang Y, Liu DZ, Ran R, Ander BP, Apperson M, et al. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J Cereb Blood Flow Metab. 2008;28:1320-8.
76. Jickling GC, Xu H, Stamova B, Ander BP, Zhan X, Tian Y, et al. Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol. 2010;68:681-92.
77. Xu H, Stamova B, Jickling G, Tian Y, Zhan X, Ander BP, et al. Distinctive RNA expression profiles in blood associated with white matter hyperintensities in brain. Stroke. 2010; 41:2744-9.
78. Jickling GC, Zhan X, Stamova B, Ander BP, Tian Y, Liu D. et al. Ischemic transient neurological events identified by immune response to cerebral ischemia. Stroke. 2012;43(4): 1006-1012.
79. Turner RJ, Bushnell CD, Register TJ, Sharp FR. Gender dependent correlations of carotid intima media thickness with gene expression in blood. Trans Stroke Res. 2011;2(2):171-178.
80. Jickling GC, Stamova B, Ander BP, Zhan X, Liu D, Sison SM, et al. Prediction of Cardioembolic, Arterial, and Lacunar Causes of Cryptogenic Stroke by Gene Expression and Infarct Location. Stroke. 2012;43(8):2036-2041.
81. Dharap A, Bowen K, Place R, Li LC, Vemuganti R. Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab. 2009;29(4):675-87.
82. Jeyaseelan K, Lim KY, Armugam A. MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion. Stroke. 2008;39(3):959-66.
83. Liu A, Zhang Z, Li A, Xue J, Effects of hypothermia and cerebral ischemia on cold-inducible RNA-binding protein mRNA expression in rat brain. Brain research. 2010;1347: 104-110.
84. Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, Wang CW, Jeyaseelan K. Expression profile of MicroRNAs in young stroke patients. PLoS One. 2009;4(11): e7689.
85. Vemuganti R, Dempsey RJ. Carotid atherosclerotic plaques from symptomatic stroke patients share the molecular fingerprints to develop in a neoplastic fashion: a microarray analysis study. Neuroscience. 2005;131:359-74.
86. Gagarin D, Yang Z, Butler J, Wimmer M, Du B, Cahan P. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL. J Mol Cell Cardiol. 2005;39:453-65.
87. Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout SD, et al. Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS One. 2009;4(9):e7037.
88. Van der Pouw Kraan TCTM, Wijbrandts CA, van Baarsen LGM, Voskuyl AE, Rustenburg F, Baggen JM, et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis. 2007;66(8):1008-14.
89. Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner M J. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol. 2008;180(3):1929-37.
90. Komatsu N, Matsueda S, Tashiro K, Ioji T, Shichijo S, Noguchi M, et al. Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination. Cancer. 2012.
91. Taub MA, Corrada Bravo H, Irizarry RA. Overcoming bias and systematic errors in next generation sequencing data. Genome Med. 2010;2:87.
92. Tian Y, Apperson ML, Ander BP, Liu D, Stomova BS, Jickling GC, et al. Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects. J Neuroimmunol. 2010:2:2.
93. Tian Y, Liao IH, Zhan X, Gunther JR, Ander BP, Liu D, et al. Exon expression and alternatively spliced genes in Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet. 2011;156:72-8.
94. Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet. 2010;11:476-86.
95. Werner T. Next generation sequencing in functional genomics. Brief Bioinform. 2010:25.